Dental caries
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Anus, Imperforate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Epithelial cyst
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Conductive hearing loss
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Orbital separation excessive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Syndactyly of fingers
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
High forehead
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Peg-shaped teeth
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Distichiasis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Lower eyelid ectropion
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital euryblepharon
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cleft palate and bilateral cleft lip
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Flat face
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal hair quantity
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Reduced number of teeth
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of vision
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
BLEPHAROCHEILODONTIC SYNDROME 2
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Carcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
Proliferative activity was measured in 165 paraffin-embedded prostatic carcinomas using DNA flow cytometric analysis of the S-phase (SPF) and G2/M-phase fractions and CAS 200 image analysis of the proliferating cell nuclear antigen (PCNA) expression defined immunohistochemically by PC10 and 19A2 monoclonal antibodies.
|
1360498 |
1992 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
DNA ploidy studies were carried out on Feulgen stained smears and cytocentrifuge preparations from 35 malignant tumours and four benign neoplasms using the CAS image analyser.
|
1723634 |
1991 |
Benign Neoplasm
|
0.010 |
GeneticVariation
|
group |
BEFREE |
DNA ploidy studies were carried out on Feulgen stained smears and cytocentrifuge preparations from 35 malignant tumours and four benign neoplasms using the CAS image analyser.
|
1723634 |
1991 |
Benign neurologic neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
DNA ploidy studies were carried out on Feulgen stained smears and cytocentrifuge preparations from 35 malignant tumours and four benign neoplasms using the CAS image analyser.
|
1723634 |
1991 |
Renal Cell Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
DNA ploidy analysis of five renal oncocytomas, six pure oncocytic-granular renal cell carcinomas, 15 pure clear cell renal carcinomas, and two cases of mixed oncocytic-granular and clear cell heterogenous renal cell carcinomas were determined on Feulgen-stained paraffin sections using the (CAS-200 image Analyzer).
|
1733409 |
1992 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
For image analysis, Feulgen-stained slides of tumor imprints and of disaggregated tumor cytospin preparations were evaluated with the CAS-200 image analyzer.
|
2047381 |
1991 |
Solid Neoplasm
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
The purpose of this study was to prospectively compare DNA quantitation from 92 solid tumors in which DNA indices had been measured by image analysis of touch preparations (CAS 100) and flow cytometry of cell suspensions (FACScan).
|
2155525 |
1990 |
Hepatoma, Novikoff
|
0.010 |
Biomarker
|
disease |
BEFREE |
The rat Novikoff hepatoma ascites cell mRNA hybridized to the p120 cDNA probes, but the p120 monoclonal antibody did not react with the Novikoff hepatoma proteins.
|
2701081 |
1989 |